Anti-Human TNFRSF4 Therapeutic Antibody (Tavolixizumab)

Recombinant monoclonal antibody to TNFRSF4. Tavolixizumab is a humanized and chimeric monoclonal antibody that can be potentially used in the treatment of Advanced Solid Tumors.
Supplier Creative Biolabs
Product # TAB-452CQ
Pricing Inquiry
Host Human
Target TNFRSF4
Species Reactivity Human
Type IgG1, κ
Applications Used for immunoassay techniques such as: Enzyme-Linked Immunosorbent Assay; Immunohistochemistry; Immunofluorescence; Immunoprecipitation; Flow Cytometry; Functional Studies
Storage Store at -20°C for long-term storage. Avoid freeze/thaw cycles.
Feedback